Canada markets closed

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.14+0.33 (+1.96%)
At close: 04:00PM EDT
17.14 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.44B
Enterprise Value 1.46B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.12
Price/Book (mrq)2.37
Enterprise Value/Revenue 4.42
Enterprise Value/EBITDA -8.12

Trading Information

Stock Price History

Beta (5Y Monthly) 1.33
52-Week Change 3-36.71%
S&P500 52-Week Change 322.38%
52 Week High 333.31
52 Week Low 314.56
50-Day Moving Average 318.87
200-Day Moving Average 320.44

Share Statistics

Avg Vol (3 month) 31.25M
Avg Vol (10 day) 31.29M
Shares Outstanding 5142.54M
Implied Shares Outstanding 6142.54M
Float 8120.17M
% Held by Insiders 113.68%
% Held by Institutions 179.15%
Shares Short (Apr 15, 2024) 49.58M
Short Ratio (Apr 15, 2024) 49.3
Short % of Float (Apr 15, 2024) 47.87%
Short % of Shares Outstanding (Apr 15, 2024) 46.72%
Shares Short (prior month Mar 15, 2024) 48.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -43.94%
Operating Margin (ttm)-59.51%

Management Effectiveness

Return on Assets (ttm)-9.40%
Return on Equity (ttm)-14.01%

Income Statement

Revenue (ttm)330.53M
Revenue Per Share (ttm)2.41
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -187.87M
Net Income Avi to Common (ttm)-145.22M
Diluted EPS (ttm)-1.06
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.03B
Total Cash Per Share (mrq)7.43
Total Debt (mrq)52.24M
Total Debt/Equity (mrq)5.07%
Current Ratio (mrq)13.65
Book Value Per Share (mrq)7.45

Cash Flow Statement

Operating Cash Flow (ttm)-357.99M
Levered Free Cash Flow (ttm)-298.35M